Cao W - Search Results

1

Complications and patient-reported outcomes after radiotherapy in breast cancer patients undergoing implant-based breast reconstruction: a retrospective study from a large Chinese breast disease center.

Ma T, Ma T, Li X, Sun X, Cao W, Niu Z, Wang H. Ma T, et al. Among authors: cao w. World J Surg Oncol. 2024 Dec 21;22(1):347. doi: 10.1186/s12957-024-03618-9. World J Surg Oncol. 2024. PMID: 39709427 Free PMC article.

2

Associations of polymorphisms of rs693 and rs1042031 in apolipoprotein B gene with risk of breast cancer in Chinese.

Liu X, Wang Y, Qu H, Hou M, Cao W, Ma Z, Wang H. Liu X, et al. Among authors: cao w. Jpn J Clin Oncol. 2013 Apr;43(4):362-8. doi: 10.1093/jjco/hyt018. Epub 2013 Feb 26. Jpn J Clin Oncol. 2013. PMID: 23444115

3

Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.

Lv ZD, Kong B, Li JG, Qu HL, Wang XG, Cao WH, Liu XY, Wang Y, Yang ZC, Xu HM, Wang HB. Lv ZD, et al. Oncol Rep. 2013 Jan;29(1):219-25. doi: 10.3892/or.2012.2111. Epub 2012 Oct 30. Oncol Rep. 2013. PMID: 23129177

4

Lentivirus-mediated inhibition of USP39 suppresses the growth of breast cancer cells in vitro.

Wang H, Ji X, Liu X, Yao R, Chi J, Liu S, Wang Y, Cao W, Zhou Q. Wang H, et al. Among authors: cao w. Oncol Rep. 2013 Dec;30(6):2871-7. doi: 10.3892/or.2013.2798. Epub 2013 Oct 14. Oncol Rep. 2013. PMID: 24126978

5

APOBEC3B expression and its prognostic potential in breast cancer.

Mao Y, Lv M, Zhang Y, Nie G, Cui J, Wang Y, Wang Y, Cao W, Liu X, Wang X, Wang H. Mao Y, et al. Among authors: cao w. Oncol Lett. 2020 Apr;19(4):3205-3214. doi: 10.3892/ol.2020.11433. Epub 2020 Mar 3. Oncol Lett. 2020. PMID: 32256817 Free PMC article.

6

Efficacy of combined therapy of goserelin and letrozole on very young women with advanced breast cancer as first-line endocrine therapy.

Liu X, Qu H, Cao W, Wang Y, Ma Z, Li F, Wang H. Liu X, et al. Among authors: cao w. Endocr J. 2013;60(6):819-28. doi: 10.1507/endocrj.ej12-0434. Epub 2013 Mar 1. Endocr J. 2013. PMID: 23714650 Free article. Clinical Trial.

7

MiR-148a suppresses invasion and induces apoptosis of breast cancer cells by regulating USP4 and BIM expression.

Zhang L, Xing M, Wang X, Cao W, Wang H. Zhang L, et al. Among authors: cao w. Int J Clin Exp Pathol. 2017 Aug 1;10(8):8361-8368. eCollection 2017. Int J Clin Exp Pathol. 2017. PMID: 31966687 Free PMC article.

8

Augmentation of antitumor function of tumor-infiltrating lymphocytes against triple-negative breast cancer by PD-1 blockade.

Song H, Wang H, Gong M, Wu L, Liu X, Cao W, Gao X, Dou R, Chen Q, Hu H. Song H, et al. Among authors: cao w. Cell Biol Int. 2022 Feb;46(2):278-287. doi: 10.1002/cbin.11729. Epub 2021 Dec 9. Cell Biol Int. 2022. PMID: 34854515

9

PIM1 is responsible for IL-6-induced breast cancer cell EMT and stemness via c-myc activation.

Gao X, Liu X, Lu Y, Wang Y, Cao W, Liu X, Hu H, Wang H. Gao X, et al. Among authors: cao w. Breast Cancer. 2019 Sep;26(5):663-671. doi: 10.1007/s12282-019-00966-3. Epub 2019 Apr 15. Breast Cancer. 2019. PMID: 30989585 Free PMC article.

10

The role of DDX46 in breast cancer proliferation and invasiveness: A potential therapeutic target.

Ma Z, Song J, Hua Y, Wang Y, Cao W, Wang H, Hou L. Ma Z, et al. Among authors: cao w. Cell Biol Int. 2023 Jan;47(1):283-291. doi: 10.1002/cbin.11930. Epub 2022 Oct 6. Cell Biol Int. 2023. PMID: 36200534

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,532 results

Search Page

Filters